Cambridge Investment Research Advisors Inc. Has $372,000 Stake in Waters Corporation (WAT)

Cambridge Investment Research Advisors Inc. held its stake in Waters Corporation (NYSE:WAT) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,025 shares of the medical instruments supplier’s stock at the close of the 2nd quarter. Cambridge Investment Research Advisors Inc.’s holdings in Waters Corporation were worth $372,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of WAT. BlackRock Inc. lifted its holdings in Waters Corporation by 2,810.7% during the first quarter. BlackRock Inc. now owns 5,349,711 shares of the medical instruments supplier’s stock worth $836,212,000 after acquiring an additional 5,165,917 shares during the period. Nomura Asset Management Co. Ltd. increased its position in Waters Corporation by 3,735.4% in the first quarter. Nomura Asset Management Co. Ltd. now owns 373,950 shares of the medical instruments supplier’s stock worth $58,452,000 after buying an additional 364,200 shares during the last quarter. Janus Capital Management LLC increased its position in Waters Corporation by 18.2% in the first quarter. Janus Capital Management LLC now owns 2,309,646 shares of the medical instruments supplier’s stock worth $361,021,000 after buying an additional 356,395 shares during the last quarter. Fundsmith LLP increased its position in Waters Corporation by 11.3% in the first quarter. Fundsmith LLP now owns 3,432,535 shares of the medical instruments supplier’s stock worth $536,540,000 after buying an additional 349,178 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in Waters Corporation by 3.0% in the first quarter. Vanguard Group Inc. now owns 7,497,760 shares of the medical instruments supplier’s stock worth $1,171,975,000 after buying an additional 216,162 shares during the last quarter. Institutional investors and hedge funds own 91.12% of the company’s stock.

WAT has been the subject of a number of recent research reports. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $202.00 target price for the company in a research report on Thursday, July 13th. BidaskClub downgraded Waters Corporation from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 28th. Jefferies Group LLC reissued a “hold” rating and issued a $175.00 target price on shares of Waters Corporation in a research report on Thursday, July 27th. Deutsche Bank AG downgraded Waters Corporation from a “buy” rating to a “hold” rating and raised their target price for the stock from $183.00 to $194.00 in a research report on Monday, July 10th. Finally, Cowen and Company reissued a “hold” rating and issued a $190.00 target price on shares of Waters Corporation in a research report on Friday, July 14th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $186.00.

Waters Corporation (NYSE:WAT) opened at 189.29 on Friday. The stock has a market capitalization of $15.11 billion, a PE ratio of 28.53 and a beta of 0.83. The stock has a 50 day moving average price of $180.64 and a 200 day moving average price of $173.26. Waters Corporation has a 12 month low of $133.35 and a 12 month high of $190.39.

Waters Corporation (NYSE:WAT) last announced its earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 EPS for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.05. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The company had revenue of $558.30 million for the quarter, compared to analysts’ expectations of $553.22 million. During the same period last year, the firm earned $1.58 EPS. Waters Corporation’s revenue for the quarter was up 4.0% compared to the same quarter last year. On average, equities research analysts forecast that Waters Corporation will post $7.38 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was first published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.chaffeybreeze.com/2017/09/15/cambridge-investment-research-advisors-inc-has-372000-stake-in-waters-corporation-wat.html.

In related news, Director Christopher A. Kuebler sold 3,500 shares of the firm’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $179.67, for a total value of $628,845.00. Following the transaction, the director now directly owns 17,849 shares of the company’s stock, valued at approximately $3,206,929.83. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Rohit Khanna sold 18,400 shares of the firm’s stock in a transaction on Friday, September 8th. The stock was sold at an average price of $185.78, for a total value of $3,418,352.00. Following the completion of the transaction, the senior vice president now directly owns 22,477 shares in the company, valued at $4,175,777.06. The disclosure for this sale can be found here. 5.07% of the stock is currently owned by company insiders.

Waters Corporation Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT).

Institutional Ownership by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply